4//SEC Filing
Graham G. Walmsley 4
Accession 0000950170-25-082306
CIK 0001744659other
Filed
Jun 4, 8:00 PM ET
Accepted
Jun 5, 4:05 PM ET
Size
6.3 KB
Accession
0000950170-25-082306
Insider Transaction Report
Form 4
Graham G. Walmsley
Director
Transactions
- Award
Common Stock
2025-06-03+9,398→ 11,566 total
Holdings
- 1,200,000(indirect: See Footnote)
Common Stock
Footnotes (2)
- [F1]These shares are represented by restricted stock units (the "RSUs"). Each RSU represents a contingent right to receive one share of Common Stock of the Issuer. The RSUs shall vest in full on the earlier of (i) June 3, 2026, and (ii) the next annual meeting of the Company's stockholders, subject to the director's continued service on the Board.
- [F2]The shares are held by Logos Global Master Fund LP ("Logos Master Fund") and Logos Opportunities Fund IV LP ("LOF IV"). Logos GP LLC ("Logos GP") is the general partner of Logos Master Fund and the Reporting Person is a managing member of Logos GP. Logos Opportunities IV GP LLC ("GP IV") is the general partner of LOF IV and the Reporting Person is a managing member of GP IV. The Reporting Person disclaims beneficial ownership of the securities except to the extent of his pecuniary interest therein.
Documents
Issuer
Akero Therapeutics, Inc.
CIK 0001744659
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001777517
Filing Metadata
- Form type
- 4
- Filed
- Jun 4, 8:00 PM ET
- Accepted
- Jun 5, 4:05 PM ET
- Size
- 6.3 KB